Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids

被引:41
|
作者
O'Brien, Melissa
McDougall, Jason J. [1 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, 5850 Coll St, Halifax, NS B3H 4R2, Canada
关键词
MANAGEMENT; PF-04457845; INHIBITOR; EFFICACY; SAFETY;
D O I
10.1016/j.coph.2018.03.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cannabis has been used for millennia to treat a multitude of medical conditions including chronic pain. Osteoarthritis (OA) pain is one of the most common types of pain and patients often turn to medical cannabis to manage their symptoms. While the majority of these reports are anecdotal, there is a growing body of scientific evidence which supports the analgesic potential of cannabinoids to treat OA pain. OA pain manifests as a combination of inflammatory, nociceptive, and neuropathic pain, each requiring modality-specific analgesics. The body's innate endocannabinoid system (ECS) has been shown to ameliorate all of these pain subtypes. This review summarizes the components of the ECS and details the latest research pertaining to plant-based and man-made cannabinoids for the treatment of OA pain. Recent pre-clinical evidence supporting a role for the ECS to control OA pain is described as well as current clinical evidence of the efficacy of cannabinoids for treating OA pain in mixed patient populations.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条
  • [1] Cannabis and Cannabinoids for Chronic Pain
    Romero-Sandoval, E. Alfonso
    Kolano, Ashley L.
    Alvarado-Vazquez, P. Abigail
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (11)
  • [2] Cannabis and Cannabinoids for Chronic Pain
    E. Alfonso Romero-Sandoval
    Ashley L. Kolano
    P. Abigail Alvarado-Vázquez
    Current Rheumatology Reports, 2017, 19
  • [3] Update on cannabis and cannabinoids for cancer pain
    Chung, Matthew
    Kim, Hee Kee
    Abdi, Salahadin
    CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (06) : 825 - 831
  • [4] Cannabis and cannabinoids in cancer pain management
    Meng, Howard
    Dai, Tianyang
    Hanlon, John G.
    Downar, James
    Alibhai, Shabbir M. H.
    Clarke, Hance
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2020, 14 (02) : 87 - 93
  • [5] Strengthening the evidence for medicinal cannabis and cannabinoids
    Freeman, Tom P.
    Morgan, Celia
    Hindocha, Chandni
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
  • [6] Cannabis, cannabinoids and schizophrenia: integration of the evidence
    Cohen, Martin
    Solowij, Nadia
    Carr, Vaughan
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (05): : 357 - 368
  • [7] Cannabis and cannabinoids for the treatment of acute and chronic pain
    Schafer, Michael
    Tafelski, Sascha
    ANAESTHESIST, 2021, 70 (07): : 551 - 562
  • [8] Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
    Baron, Eric P.
    HEADACHE, 2018, 58 (07): : 1139 - 1186
  • [9] Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence
    Chye, Yann
    Kirkham, Rebecca
    Lorenzetti, Valentina
    McTavish, Eugene
    Solowij, Nadia
    Yucel, Murat
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 627 - 635
  • [10] Pain and cannabinoids: science and evidence
    Farquhar-Smith, WP
    PAIN REVIEWS, 2002, 9 (01): : 41 - 67